View in EDS PDF Full Text

Is meningococcal B vaccination needed in the post-COVID-19 world?

Saved in:
Bibliographic Details
Title: Is meningococcal B vaccination needed in the post-COVID-19 world?
Alternate Title: ¿Es necesaria la vacunación contra el meningococo B en el mundo pos-COVID-19?
Authors: Portilho, Amanda Izeli1,2, De Gaspari, Elizabeth1,2 elizabeth.gaspari@ial.sp.gov.br
Source: Biomédica: Revista del Instituto Nacional de Salud. sep2025, Vol. 45 Issue 3, p359-368. 10p.
Subjects: MENINGOCOCCAL infections, MENINGOCOCCAL vaccines, COVID-19 pandemic, BACTERIAL meningitis, BACTERIAL diseases
Abstract (English): Neisseria meningitidis is the main cause of bacterial meningitis worldwide and is transmitted through respiratory secretions. Meningitis is a serious public health problem because of its high morbidity and mortality rates and the risk of causing epidemics. Although vaccines are available to prevent meningococcal disease, serogroup B infections are still challenging, given that many countries do not include meningococcal B vaccines in their national immunization programs. In addition, recent data suggests somewhat sustained N. meningitidis B infections during the COVID-19 pandemic and increasing levels of meningococcal disease after its control. These findings agree with previous observations indicating that respiratory viruses facilitate respiratory bacterial infections. This essay intends to present epidemiological data on meningococcal disease and discusses studies exploring why the prevention of bacterial and viral infections is an intricate subject. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Neisseria meningitidis es la principal causa de meningitis bacteriana en el mundo y es transmitida mediante secreciones respiratorias. La meningitis es un grave problema de salud pública debido a sus grandes tasas de morbilidad y mortalidad, y por el riesgo de generar epidemias. Aunque existen vacunas para prevenir la enfermedad meningocócica, la infección por el serogrupo B sigue siendo un desafío, ya que muchos países no han incluido estas vacunas en sus programas nacionales de inmunización. Además, datos recientes sugieren la persistencia de infecciones causadas por el serogrupo B de N. meningitidis durante la pandemia de COVID-19 y un incremento en los niveles de enfermedad meningocócica tras su contención. Esta información coincide con observaciones previas que afirman que los virus respiratorios facilitan las infecciones bacterianas respiratorias. Este ensayo pretende presentar datos epidemiológicos de la enfermedad meningocócica y discutir aquellos estudios que resaltan la complejidad de la prevención de las infecciones bacterianas y virales. [ABSTRACT FROM AUTHOR]
Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 187402495
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Is meningococcal B vaccination needed in the post-COVID-19 world?
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: ¿Es necesaria la vacunación contra el meningococo B en el mundo pos-COVID-19?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Portilho%2C+Amanda+Izeli%22">Portilho, Amanda Izeli</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22De+Gaspari%2C+Elizabeth%22">De Gaspari, Elizabeth</searchLink><relatesTo>1,2</relatesTo><i> elizabeth.gaspari@ial.sp.gov.br</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Biomédica%3A+Revista+del+Instituto+Nacional+de+Salud%22">Biomédica: Revista del Instituto Nacional de Salud</searchLink>. sep2025, Vol. 45 Issue 3, p359-368. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22MENINGOCOCCAL+infections%22">MENINGOCOCCAL infections</searchLink><br /><searchLink fieldCode="DE" term="%22MENINGOCOCCAL+vaccines%22">MENINGOCOCCAL vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+pandemic%22">COVID-19 pandemic</searchLink><br /><searchLink fieldCode="DE" term="%22BACTERIAL+meningitis%22">BACTERIAL meningitis</searchLink><br /><searchLink fieldCode="DE" term="%22BACTERIAL+diseases%22">BACTERIAL diseases</searchLink>
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Neisseria meningitidis is the main cause of bacterial meningitis worldwide and is transmitted through respiratory secretions. Meningitis is a serious public health problem because of its high morbidity and mortality rates and the risk of causing epidemics. Although vaccines are available to prevent meningococcal disease, serogroup B infections are still challenging, given that many countries do not include meningococcal B vaccines in their national immunization programs. In addition, recent data suggests somewhat sustained N. meningitidis B infections during the COVID-19 pandemic and increasing levels of meningococcal disease after its control. These findings agree with previous observations indicating that respiratory viruses facilitate respiratory bacterial infections. This essay intends to present epidemiological data on meningococcal disease and discusses studies exploring why the prevention of bacterial and viral infections is an intricate subject. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Neisseria meningitidis es la principal causa de meningitis bacteriana en el mundo y es transmitida mediante secreciones respiratorias. La meningitis es un grave problema de salud pública debido a sus grandes tasas de morbilidad y mortalidad, y por el riesgo de generar epidemias. Aunque existen vacunas para prevenir la enfermedad meningocócica, la infección por el serogrupo B sigue siendo un desafío, ya que muchos países no han incluido estas vacunas en sus programas nacionales de inmunización. Además, datos recientes sugieren la persistencia de infecciones causadas por el serogrupo B de N. meningitidis durante la pandemia de COVID-19 y un incremento en los niveles de enfermedad meningocócica tras su contención. Esta información coincide con observaciones previas que afirman que los virus respiratorios facilitan las infecciones bacterianas respiratorias. Este ensayo pretende presentar datos epidemiológicos de la enfermedad meningocócica y discutir aquellos estudios que resaltan la complejidad de la prevención de las infecciones bacterianas y virales. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=187402495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7705/biomedica.7423
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 359
    Subjects:
      – SubjectFull: MENINGOCOCCAL infections
        Type: general
      – SubjectFull: MENINGOCOCCAL vaccines
        Type: general
      – SubjectFull: COVID-19 pandemic
        Type: general
      – SubjectFull: BACTERIAL meningitis
        Type: general
      – SubjectFull: BACTERIAL diseases
        Type: general
    Titles:
      – TitleFull: Is meningococcal B vaccination needed in the post-COVID-19 world?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Portilho, Amanda Izeli
      – PersonEntity:
          Name:
            NameFull: De Gaspari, Elizabeth
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: sep2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 01204157
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Biomédica: Revista del Instituto Nacional de Salud
              Type: main
ResultId 1